Electrolytes are ordered more than almost anything else and questioned less than almost anything else. A sodium of 128 comes back, somebody starts correcting it, and nobody asks what the analyser did to arrive at that figure.
Occasionally they should.
An ion-selective electrode works on a simple idea. A membrane selectively permeable to one ion develops a potential across it proportional to that ion's activity in the solution. Measure the potential against a reference, and you have a concentration. Different membranes for sodium, potassium, chloride and lithium.
What makes this worth understanding is that there are two ways to present the sample to that electrode, and they can disagree.
## Direct and indirect, and why it matters
Direct ISE measures undiluted sample. The electrode sees plasma as it is, and reports the ion activity in the water phase.
Indirect ISE dilutes the sample first, then measures. Most general chemistry analysers do it this way because it fits the existing fluidics. The calculation back to concentration assumes a normal proportion of plasma that is water — around 93 per cent.
For most patients, both give the same answer. The exception is the patient whose plasma is not mostly water.
In severe hyperlipidaemia or marked hyperproteinaemia, lipid or protein occupies volume that would normally be water. The sodium concentration in the water phase is perfectly normal. But the indirect calculation, assuming a water fraction that is no longer true, reports a low sodium. Pseudohyponatraemia.
It is not common, but it is the sort of result that starts a treatment. If a low sodium arrives from a visibly lipaemic sample, that is worth confirming on a direct system before anybody acts on it. Dedicated electrolyte analysers such as the Roche electrolyte analyser and blood gas systems with integrated electrolytes like the ST-200 generally use direct measurement, which is a genuine clinical advantage in exactly this situation.
Hyperglycaemia is a different matter, and worth not confusing with the above. There the sodium really is diluted, by water drawn osmotically into the vascular space. That is true hyponatraemia and it needs correcting for glucose before interpretation.
## What actually goes wrong day to day
Not the technology. The electrodes and the samples.
Electrodes age. Slope and response time degrade slowly, and the failure is gradual rather than sudden, which is exactly why it is missed. Daily QC plotted rather than filed is what catches it — a run of results drifting toward one edge of the range over a fortnight is an electrode telling you it is tiring.
Protein deposits on the membrane. Regular conditioning and deproteinisation per the manufacturer's schedule is dull, unglamorous work that determines how long the electrode lasts. Laboratories that skip it replace electrodes far more often and usually blame the supplier.
Air bubbles in the sample path give erratic readings, often obviously wrong, occasionally not.
And potassium remains the analyte where the pre-analytical phase does most of the damage. Haemolysis, delayed separation, cold transport, EDTA carryover from the wrong order of draw. A raised potassium from a collection centre two hours away, in a patient who looks well, deserves a look at the sample before it becomes a phone call.
## Calibration and the range
Two-point calibration at the frequency the manufacturer specifies, plus after any electrode change or maintenance.
Verify across the reportable range rather than only at the two QC levels. Your QC sits near the clinical decision points in the middle, which tells you nothing about performance at a sodium of 115 or a potassium of 7 — precisely the values that will be acted on most urgently.
## On the report
State whether your method is direct or indirect somewhere your users can find it, even if only in the user handbook. It is the single piece of information that explains a discrepancy between your result and another laboratory's, and almost nobody publishes it.